Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Substrate Targeted Ablation Using the FlexAbility™ Ablation Catheter System for the Reduction of Ventricular Tachycardia (STAR-VT) - G130132

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT02130765
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:37:00.950038+00:00
Published At
2018-10-15T00:00:00+00:00
Record Updated At
2019-02-12
Results Posted At
2018-10-15
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Monomorphic Ventricular Tachycardia"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2019-02-12"
protocolSection.identificationModule.nctId
"NCT02130765"
protocolSection.identificationModule.officialTitle
"Substrate Targeted Ablation Using the FlexAbility\u2122 Ablation Catheter System for the Reduction of Ventricular Tachycardia (STAR-VT) - G130132"
protocolSection.statusModule.overallStatus
"TERMINATED"
protocolSection.designModule.phases
["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2018-10-15"

Study condition terms

  • Monomorphic Ventricular Tachycardia (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.